Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Oberbach, Andreas ^a   Schlichting, Nadine ^a   Blüher, Matthias ^a   Kovacs, Peter ^b   Till, Holger ^a   Stolzenburg, Jens Uwe ^a   Neuhaus, Jochen ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FATTY ACID; GLYCOPROTEIN; GLYCOPROTEIN GP 130; GLYCOPROTEIN GP 80; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PALMITIC ACID; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BACTERIAL INFECTION; BLADDER MUSCLE; CELL STIMULATION; CELL TYPE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INTRACELLULAR SIGNALING; METABOLIC REGULATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER; UPREGULATION; URINARY TRACT INFECTION; WESTERN BLOTTING;

CELL LINE; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MYOCYTES, SMOOTH MUSCLE; PALMITATES; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTOR RELA; URINARY BLADDER; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS);

EID: 77956289866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010882     Document Type: Article

References (31)

1. Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50: 549-554.
2. Stapleton A (2002) Urinary tract infections in patients with diabetes. Am J Med 113 Suppl 1A: 80S-84S.
3. Schneeberger C, Stolk RP, Devries JH, Schneeberger PM, Herings RM, et al. (2008) Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes. Diabetes Care 31: 1380-1385.
4. Hoepelman AI, Meiland R, Geerlings SE (2003) Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 22 Suppl 2: 35-43.
5. Harding GK, Zhanel GG, Nicolle LE, Cheang M (2002) Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 347: 1576-1583.
6. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Collet TJ, et al. (2000) Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 23: 1737-1741.
7. Wilding JP (2007) The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 24: 934-945.
8. Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P (2006) Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha. Urology 67: 214-219.
9. Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG, et al. (2001) Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 5: 147-160.
10. Otto G, Braconier J, Andreasson A, Svanborg C (1999) Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Infect Dis 179: 172-179.
11. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
12. Festa A, D'Agostino RJ, Tracy RP, Haffner SM (2002) C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 19: 939-943.
13. Weigert C, Brodbeck K, Staiger H, Kausch C, Machicao F, et al. (2004) Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J Biol Chem 279: 23942-23952.
14. Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, et al. (2004) Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53: 3209-3216.
15. Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419: 101-109.
16. Eitel K, Staiger H, Rieger J, Mischak H, Brandhorst H, et al. (2003) Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes 52: 991-997.
17. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME (2009) The c-Jun Nterminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes. Horm Metab Res 41: 523-530.
18. Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL (2009) 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3- L1 adipocytes. Obesity (Silver Spring) 17: 1657-1663.
19. Ishikado A, Nishio Y, Yamane K, Mukose A, Morino K, et al. (2009) Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells. Atherosclerosis 205: 404-412.
20. Ajuwon KM, Spurlock ME (2005) Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 135: 1841-1846.
21. Yohannes E, Chang J, Christ GJ, Davies KP, Chance MR (2008) Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction. Mol Cell Proteomics 7: 1270-1285.
22. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
23. Zhao S, Yang YN, Song JG (2004) Ceramide induces caspase-dependent and - independent apoptosis in A-431 cells. J Cell Physiol 199: 47-56.
24. Stampfer MJ, Rimm EB (1996) Folate and cardiovascular disease. Why we need a trial now. JAMA 275: 1929-1930.
25. Lim JH, Um HJ, Park JW, Lee IK, Kwon TK (2009) Interleukin-1beta promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways. Exp Mol Med 41: 757-764.
26. Reape TJ, Groot PH (1999) Chemokines and atherosclerosis. Atherosclerosis 147: 213-225.
27. Bouchelouche K, Andresen L, Alvarez S, Nordling J, Nielsen OH, et al. (2006) Interleukin-4 and 13 Induce the Expression and Release of Monocyte Chemoattractant Protein 1, Interleukin-6 and Stem Cell Factor From Human Detrusor Smooth Muscle Cells: Synergy With Interleukin-1beta and Tumor Necrosis Factor-alpha. J Urol 175: 760-765.
28. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
29. Rose-John S, Scheller J, Elson G, Jones SA (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80: 227-236.
30. Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4: 540-545.
31. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R (1999) Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48: 855-864.